AI-Assisted Staging and Treatment Planning for Liver Cancer
Part of Cancer, Digestive system clinical trials.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have newly diagnosed or suspected primary liver cancer (HCC), confirmed by biopsy or imaging criteria
- You have complete baseline blood tests, liver function tests, and a contrast-enhanced CT scan of your abdomen done before starting the trial
- You have not received any anti-cancer treatment for liver cancer yet
- You or your legal representative can provide written informed consent to use your medical data in the trial
- You do not have cancer that has spread from another organ, and no other serious cancers at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study uses artificial intelligence to look at tumor samples and MRI scans from people with advanced liver cancer to help choose the best treatment. It aims to make treatment more personalized and effective.
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This study tests whether an artificial intelligence system can help doctors find and treat liver cancer if it comes back after your first surgery or ablation. It focuses on early detection and providing another curative treatment if a recurrence is found.
This study uses a computer program to help doctors look for cancer in the liver on CT scans. It aims to see if the AI tool makes reading scans faster and more accurate, which could help catch issues sooner.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.